< >

Contact Uscontact

Parc Euromédecine, Cap Gamma
1682 Rue de la Valsière - CS17383
34189 Montpellier cedex 4 - FRANCE

Office +33 (0)4 67 727 670
FAX : +33 (0)4 67 727 679


3 oncology-focused projects, including novel targeted therapies (molecules and antibodies), under development and potentially available for licensing or collaboration.
» Read more ...


04/25/13 : OriBase Pharma is entitled to taxes return for investment

Thanks to a first round of fund raising realized successfully ( 1 500 000€), involving 52 investors, we were able...
» Read more ...

Dedicated to the development of new generation of kinase inhibitors based drug candidates

OriBase Pharma is fully dedicated to the discovery & early development of novel & best-in-class targeted therapies (kinase inhibitors) from discovery to clinical validation for indications with high and unmet medical needs in oncology.

Our mission is to deliver safe, drug-like novel molecular entities (NCEs and NBEs) ready for clinical trials through the application of a unique technology platform & efficient discovery processes. Our commitment is to accomplish this with the highest quality & speed.

Scientific Advisory BoardScientific Advisory Board

OriBase Pharma is supported by a highly experienced Scientific Advisory Board that has followed the company since its creation in 2007 (formerly Nova Decision & Azasynth...
Read more ...

Kinase InhibitorKinase Inhibitor

Our expertise comes from the deep understanding of the various mechanisms of potential inhibitors and their interaction and binding kinases.
Read more ...



OSEOLa Région Languedoc-RoussillonINSERMLanguedoc Roissillon Incubation